Ruxolitinib phosphate is the phosphate salt form of ruxolitinib, used to treat specific blood-related disorders, polycythemia vera, steroid-refractory acute graft-versus-host disease, and atopic dermatitis. Ruxolitinib is marketed as Jakafi by Incyte Corp in the United States and Jakavi by Novartis throughout the rest of the world. Table of Contents What is Ruxolitinib? Ruxolitinib is a […]